PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment
Clinical trial NCT07028424 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07028424
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2029-07-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.